title: Successful management of liver injury caused by imatinib mesylate in a patient with previously untreated chronic myelogenous leukemia in the chronic phase.
authors.forename: Rie
authors.initials: R
authors.lastname: Yamazaki
authors.forename: Shinichiro
authors.initials: S
authors.lastname: Okamoto
authors.forename: Chien-Kang
authors.initials: CK
authors.lastname: Chen
authors.forename: Shinichiro
authors.initials: S
authors.lastname: Tada
authors.forename: Hidetane
authors.initials: H
authors.lastname: Saito
authors.forename: Rie
authors.initials: R
authors.lastname: Shibata
authors.forename: Michiie
authors.initials: M
authors.lastname: Sakamoto
authors.forename: Takehiko
authors.initials: T
authors.lastname: Mori
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Ikeda
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D001549:Benzamides; D001706:Biopsy; D001752:Blast Crisis; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008099:Liver / Q000293:injuries* / Q000473:pathology; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use*; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate